Cover Image
市場調查報告書

子宮內膜異位症:主要9個國家的市場預測

Endometriosis Forecast in 9 Major Markets 2015-2025

出版商 Black Swan Analysis 商品編碼 339881
出版日期 內容資訊 英文 36 Pages
訂單完成後即時交付
價格
Back to Top
子宮內膜異位症:主要9個國家的市場預測 Endometriosis Forecast in 9 Major Markets 2015-2025
出版日期: 2015年09月01日 內容資訊: 英文 36 Pages
簡介

子宮內膜異位症是在子宮外側發現一般生長在子宮 (子宮內膜) 內側的細胞之婦科疾病。這是會引起嚴重的月經、下腹部疼痛,以及不孕問題的慢性疾病。

本報告提供全球主要9個國家(美國,法國,德國,義大利,西班牙,英國,巴西,日本,印度) 的子宮內膜異位症發病情形相關分析,提供您疾病概要和目前的患病人數,性別·各年代 (以五歲為區分) 的詳細情況,各地區·各民族趨勢,風險要素,疾病診斷與預後,主要的症狀和併發症,未來性的趨勢預測 (今後10年份) 等資訊,為您概述為以下內容。

圖表

簡介

疾病的原因

風險要素與預防法

疾病診斷

各地區/各民族的差異

疾病的預後與臨床經過

疾病相關的主要併發症/特徵

患者數的定量化技術

子宮內膜異位症的最大患病人數

子宮內膜異位症的主要位置

子宮內膜異位症的主要併發症·後遺症

參考文獻

附錄

目錄
Product Code: ENDO0010915

Summary

Endometriosis is a gynaecological condition where tissue that normally behaves like the lining of the womb (endometrium) is found outside the womb. These pieces of tissue are commonly found on the ovaries and the lining of the pelvis behind the uterus. This is a chronic condition that causes heavy periods, lower abdominal pain and can cause fertility issues. This report provides the current prevalent population for Endometriosis across 9 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan and India) split by gender and 5-year age cohort. Along with the current prevalence, the report provides an overview of the types, occlusion locations and the prevalence of associated disorders of Endometriosis. The report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Endometriosis have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Endometriosis include:

  • Infertility
  • Pelvic Pain
  • Fibroids
  • Ovarian cysts

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

  • Able to quantify patient populations in global Endometriosis's market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the prevalence of the subdivided types of Endometriosis and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on Endometriosis's prevalent population.
  • Examination of the prevalence of the different causative gene mutations for Endometriosis.
  • Identify sub-populations within Endometriosis which require treatment.
  • Gain an understanding of the specific markets that have the largest number of Endometriosis patients.

Table of Contents

  • List of Tables and Figures
  • Introduction
  • Cause of the Disease
  • Risk Factors and Prevention
  • Diagnosis of the Disease
  • Variation by Geography /Ethnicity
  • Disease Prognosis and Clinical Course
  • Key Co-Morbid Conditions / Features Associated with the Disease
  • Methodology for Quantifications of Patient Number
  • Top Line Prevalence for Endometriosis
  • Main Site of Endometriosis
  • Key Concomitant Conditions and Sequaelae of Endometriosis
  • References
  • Appendix

List of Tables and Figures

  • Prevalence of Endometriosis, females only (000s)
  • Prevalence of Endometriosis by Stage, females only (000s)
  • Endometriosis by Main Site, females only (000s)
  • Prevalence of Infertility in Patients with Endometriosis, females only (000s)
  • Prevalence of Ovarian Cysts in Patients with Endometriosis, females only (000s)
  • Endometriosis Patients with Chronic Pelvic Pain, females only (000s)
  • Prevalence of Fibroids in Patients with Endometriosis, females only (000s)
  • Endometriosis Patients with Incapacitating Dysmenorrhoea, females only (000s)
  • Endometriosis Patients with Cyclical Intestinal Complaints, females only (000s)
  • Endometriosis Patients wit Cyclical Urinary Complaints, females only (000s)
  • Endometriosis Patients with Deep Dyspareuria, females only (000s)
  • USA Prevalence of Endometriosis by 5-yr age cohort, females (000s)
  • France Prevalence of Endometriosis by 5-yr age cohort, females (000s)
  • Germany Prevalence of Endometriosis by 5-yr age cohort, females (000s)
  • Italy Prevalence of Endometriosis by 5-yr age cohort, females (000s)
  • Spain Prevalence of Endometriosis by 5-yr age cohort, females (000s)
  • United Kingdom Prevalence of Endometriosis by 5-yr age cohort, females (000s)
  • Brazil Prevalence of Endometriosis by 5-yr age cohort, females (000s)
  • Japan Prevalence of Endometriosis by 5-yr age cohort, females (000s)
  • India Prevalence of Endometriosis by 5-yr age cohort, females (000s)
Back to Top